| Ytd | 5.17% | |
| 1y | -38.33% |
| Open | 14.34 | Prev Close | 14.48 | Low | 14.26 | High | 14.70 | Mkt Cap | 2.03B |
| Vol | 2.47M | Avg Vol | 3.41M | EPS | -12.29 | P/E | N/A | Forward P/E | 6.11 |
| Beta | 0.54 | Short Ratio | 7.52 | Inst. Own | 120.64% | Dividend | 1.16 | Div Yield | 8.01 |
| Ex Div Date | 08-28 | Earning | 11-04 | 50-d Avg | 11.47 | 200-d Avg | 12.18 | 1yr Est | 16.50 |
DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consum
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO)
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector.
I present my August top 5 dividend picks: PRGO, MZTI, NEE, TROW, and VICI, all rated Buy or Strong B
Perrigo Company remains substantially undervalued, with a Buy rating justified by strong income and
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO)
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
Perrigo NYSE: PRGO reported second-quarter 2026 results that exceeded its internal earnings expectat
PRGO tops Q2 EPS estimates as Infant Formula sales jump, helping offset softer demand and divestitur
Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday'
The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter e
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re
Perrigo (PRGO) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estim
Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.50 per share which beat the analyst consensus
Execution of Three-S plan driving continued improvement in underlying business fundamentals, includi
DUBLIN, July 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consum
DUBLIN, July 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consum
DUBLIN, July 22, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consum
DUBLIN, June 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo"), a leading provid
Jim Cramer recommends buying Constellation Energy (CEG) as it has come down too far. ManpowerGroup (
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 200 points on Tu
U.S. stock futures higher, Nasdaq up 200 points. Mission Produce (NASDAQ: AVO) shares down on weak e
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal cond
Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading provider of
Albert A. Manzone Appointed Interim President and CEO Patrick Lockwood-Taylor Resigns as President a
Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.43 per share which beat the analyst consensus
https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, se
Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst
Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and lowers the
Perrigo (NYSE:PRGO) is looking for FY2026 Adj EPS of $2.25-$2.55 vs $2.65 analyst estimate. sees sal
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.77 per share which missed the analyst consensu
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_decembe
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_decembe
Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and lowers the
JP Morgan analyst Chris Schott downgrades Perrigo (NYSE:PRGO) from Overweight to Neutral and lowe